468
Views
42
CrossRef citations to date
0
Altmetric
Genodermatoses

Successful treatment of angiofibromata of tuberous sclerosis complex with rapamycin

, &
Pages 46-48 | Received 19 Apr 2010, Accepted 20 Apr 2010, Published online: 01 Aug 2010
 

Abstract

Tuberous sclerosis complex (TSC) is an autosomal dominant neurocutaneous syndrome manifesting as hamartomatous growths in multiple organs. We present two cases of patients with TSC and associated facial angiofibromata treated with topical and oral rapamycin and discuss the role for rapamycin in the treatment of these disfiguring lesions. Our patients demonstrated decreased numbers of angiofibromata and less redness with this treatment. This is the first published report on the use of topical rapamycin for the treatment of angiofibromata.

Acknowledgements

The Center for Dermatology Research is supported by an educational grant from Galderma Laboratories, L.P.

Declaration of interest: Alan B. Fleischer, Jr., reports the following conflicts of interest (applicable to a 5-year-period). Advisory Board member: Allergan, Amgen, Astellas, Galderma, GSK, Ortho Dermatologics, Stiefel; consultant for: Allergan, Astellas, Asubio, Combe, Galderma, Gerson Lehrman, Intendis, Kikaku America International, Merz, Novartis, Serentis, Taisho; investigator for: 3M, Abbott, Amgen, Astellas, Asubio, BioCryst, Biogen, Centocor, Coria, Dow, Galderma, Genentech, GSK, Intendis, Medicis, Novartis, Ortho Dermatologics, Pfizer, Serentis, Stiefel, Taisho; Speaker Bureau: Amgen, Astellas, Galderma, Intendis, Medicis, Novartis, Stiefel, Upsher-Smith; stockholder: none.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.